Research News

Taking Statins Linked to Lower Mortality in Ovarian Cancer Patients

(July 7, 2020) Presented as part of the American Association for Cancer Research (AACR) Virtual Annual Meeting, Dr…

Read on

Finding Sparks, Fueling Motivation | Meet a Scientist

Hui Shen, PhD, spoke of a particular moment that helped cement her commitment to ovarian cancer research. She was working on a complicated project that required a new genomics technology to work…

Read on

Healthy Lifestyle Linked to Better Prognosis

(June 24, 2020) Published this month in the International Journal of Cancer, researchers in Australia have found that “A healthy lifestyle after diagnosis, in particular not smoking and being physically active, may help women with ovarian cancer…

Read on

OCRA Now Accepting Applications for 2021 Research Grants

(June 11, 2020) Letters of Intent (LOIs) for Ovarian Cancer Research Alliance’s 2021 scientific grant awards are now open for submission. LOIs are due by July 10, 2020. Accepting LOIs is step one of OCRA’s highly competitive grant process…

Read on

Convenient Spit Test Helps Women Assess Cancer Risk From the Comfort of Their Own Home

First-of-its-kind clinical trial validates remote genetic counseling (New York) June 01, 2020 – Genetic testing for cancer risk can significantly improve the prevention or treatment of hereditary cancers, but studies have shown that people who…

Read on

When a Virus is a Good Thing | Meet a Scientist

Scared. Overwhelmed. Exhausted. Befuddled.  These are common words one might use to describe how we feel during this unprecedented time in history…

Read on

Niraparib Receives FDA Approval as First-Line Maintenance Therapy for Advanced Ovarian Cancer

(May 4, 2020) On April 29th, the Food and Drug Administration approved niraparib (Zejula, GlaxoSmithKline) as a first-line maintenance treatment for advanced epithelial ovarian, fallopian tube, or primary peritoneal cancer, regardless of BRCA…

Read on

SGO 2020 Highlights

(April 17, 2020) The Society of Gynecologic Oncology’s Annual Meeting on Women’s Cancer brings together women’s healthcare professionals from across the globe to discuss the latest findings in gynecologic oncology…

Read on

COVID-19 and Oncology Clinical Trials: An Update

(April 15) The novel coronavirus, COVID-19, has become nearly all consuming. It’s impossible to turn on the news, browse social media, or walk outside without being reminded of the new, albeit temporary, state of the world…

Read on

Working for the Next Generation | Meet a Scientist

There are many adjectives one can use to describe ovarian cancer: relentless, cruel, a monster. But Dr. Sunila Pradeep also finds it ironic. “Women spend a lot of time and energy for the next generation…

Read on

Study Uncovers Barriers to Clinical Trial Participation

(April 9, 2020) Why do some gynecologic cancer patients participate in clinical trials, while others do not? Clinical trials are fundamental to the discovery of new and better therapies in the fight against ovarian cancer…

Read on

Update to Benefits of Breastfeeding Against Ovarian Cancer

(April 7, 2020) In a study published last week in the oncology Journal of the American Medical Association, breastfeeding was found to be a factor for reduced risk of developing invasive ovarian cancer…

Read on